Abstract
This case report discusses a 75-year-old patient with mild cognitive impairment who successfully continued driving while treated with lecanemab. The treatment appeared to stabilize cognitive function and facilitate ongoing physical activity, potentially reducing informal care burdens associated with driving cessation. Further research is warranted to explore long-term impacts.